Siddharth Kaul

Sid Kaul was appointed to the Immunocore Board of Directors as a Non-Executive Director in June 2022. Sid retired from Novartis as Group Treasurer and Head of Business Planning and Analysis in April 2021 after a 17-year career there. He led Novartis’s Strategic Review and Spin-Off for the Alcon (eye care) business. Sid joined Novartis as CFO of Pharma Europe and subsequently served as CFO of Pharma US following a 20-year career with Procter & Gamble in Financial Planning & Analysis, Strategic Planning, Accounting, and Auditing in the US and Japan.